PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Journal of the American College of Cardiology345 citations

Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease

View Full Paper
ÁAÁngel ArenalElectrophysiologyEGEsteban Glez-TorrecillaHospital General Universitario Gregorio MarañónMOMercedes OrtizUniversidad Autónoma del Estado de México

Structured PICO

Does radiofrequency ablation guided by electrograms with isolated, delayed components (E-IDC) reduce VT recurrence in patients with unmappable monomorphic ventricular tachycardia and structural heart disease?

P
Population
24 patients with documented monomorphic ventricular tachycardia (VT) and structural heart disease (21 ischemic cardiomyopathy, 2 nonischemic cardiomyopathy, 1 tetralogy of Fallot). 12 patients had an implantable cardioverter-defibrillator. 18 patients had unmappable VT (noninducible or not tolerated).
I
Intervention
Radiofrequency ablation guided by endocardial electroanatomic activation mapping (Carto System) to target areas with electrograms displaying isolated, delayed components (E-IDC) during sinus rhythm and right ventricular apex (RVA) pacing.
O
Outcome
Suppression of clinical VT inducibility and recurrence of VT during follow-up.hard clinical

Radiofrequency ablation targeting electrograms with isolated, delayed components during right ventricular apex pacing is a feasible and effective strategy for controlling unmappable monomorphic ventricular tachycardia in patients with structural heart disease.

Abstract

OBJECTIVES: We sought to evaluate the feasibility of identifying and ablating the substrate of unmappable ventricular tachycardia (VT). BACKGROUND: Noninducible and nonstable VT cannot be ablated by the conventional approach. METHODS: We studied 24 patients with documented monomorphic VT. Twenty-one patients had ischemic cardiomyopathy, two had nonischemic cardiomyopathy, and one had tetralogy of Fallot. Twelve patients had an implantable cardioverter-defibrillator. Conventional activation mapping was not possible in 18 patients: at least 1 of the clinical VTs or the clinical VT was not inducible in 12 patients, and VT was not tolerated in 6 patients. This group had experienced between 1 and 106 VT episodes in the month before the ablation procedure. Endocardial electroanatomic activation maps (Carto System) during sinus rhythm (SR) and right ventricular apex (RVA) pacing were obtained to define areas for which an electrogram displayed isolated, delayed components (E-IDC). These electrograms were characterized by double or multiple components separated by >/=50 ms. RESULTS: One area of E-IDC was recorded in 20 patients, and 2 or more were recorded in 4 patients. In 23 patients, these areas were detected during RVA pacing; in only 14 during SR. An E-IDC area related to the clinical VT was identified in each patient. Ablation guided by E-IDC suppressed all but one clinical VT whose inducibility suppression was tested. During a follow-up period of 9 +/- 4 months, three patients had recurrences of the ablated VT and two of a different VT. CONCLUSIONS: Electrograms with IDCs related to clinical VT can be identified in the majority of patients during RVA pacing. Radiofrequency ablation of E-IDC seems effective in controlling unmappable VT.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Arenal et al. (2002) studied this question.

synapsesocial.com/papers/69fb5be7c8bb648e6527463ehttps://doi.org/10.1016/s0735-1097(02)02623-2
Ask AI
Helpful
Bookmark
Share
View Full Paper